The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study
Abstract
Among the 1846 patients in the HEMO Study, chronic high-flux dialysis did not significantly affect the primary outcome of the all-cause mortality (ACM) rate or the main secondary composite outcomes, including the rates of first cardiac hospitalization or ACM, first infectious hospitalization or ACM, first 15% decrease in serum albumin levels or ACM, or all non-vascular access-related hospitalizations. The high-flux intervention, however, seemed to be associated with reduced risks of specific cardiac-related events. The relative risks (RR) for the high-flux arm, compared with the low-flux arm, were 0.80 [95% confidence interval (CI), 0.65 to 0.99] for cardiac death and 0.87 (95% CI, 0.76 to 1.00) for the composite of first cardiac hospitalization or cardiac death. Also, the effect of high-flux dialysis on ACM seemed to vary, depending on the duration of prior dialysis. This report presents secondary analyses to further explore the relationship between the flux intervention and the duration of dialysis with respect to various outcomes. The patients were stratified into a short-duration group and a long-duration group, on the basis of the mean duration of dialysis of 3.7 yr before randomization. In the subgroup that had been on dialysis for >3.7 yr, randomization to high-flux dialysis was associated with lower risks of ACM (RR, 0.68; 95% CI, 0.53 to 0.86; P = 0.001), the composite of first albumin level decrease or ACM (RR, 0.74; 95% CI, 0.60 to 0.91; P = 0.005), and cardiac deaths (RR, 0.63; 95% CI, 0.43 to 0.92; P = 0.016), compared with low-flux dialysis. No significant differences were observed in outcomes related to infection for either duration subgroup, however, and the trends for beneficial effects of high-flux dialysis on ACM rates were considerably weakened when the years of dialysis during the follow-up phase were combined with the prestudy years of dialysis in the analysis. For the subgroup of patients with <3.7 yr of dialysis before the study, assignment to high-flux dialysis had no significant effect on any of the examined clinical outcomes. These data suggest that high-flux dialysis might have a beneficial effect on cardiac outcomes. Because these results are derived from multiple statistical comparisons, however, they must be interpreted with caution. The subgroup results that demonstrate that patients with different durations of dialysis are affected differently by high-flux dialysis are interesting and require further study for confirmation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
Self-citationOwen, W. F., Lew, N. L., Liu, Y., Lowrie, E. G., & Lazarus, J. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291404 · Cited by 1,404
United States Renal Data System (USRDS).
Agodoa, L. (2000) · PubMed · Cited by 490
Self-citationAmino acid and albumin losses during hemodialysis
Alp Ikizler, T., Flakoll, P. J., Parker, R. A., & Hakim, R. M. (1994) · Kidney International · doi:10.1038/ki.1994.339 · Cited by 383
Kaysen, G. A., Dubin, J. A., Müller, H.-G., Mitch, W. E., Rosales, L. M., Levin, N. W., & the HEMO Study Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00076.x · Cited by 280
Self-citationPhagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study
Vanholder, R., Ringoir, S., Dhondt, A., Hakim, R., Waterloos, W. T. T. A. O. M.-A., Lantschoot, N. V., & Gung, A. (1991) · Kidney International · doi:10.1038/ki.1991.40 · Cited by 205
Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial
Miskulin, D. C., Athienites, N. V., Yan, G., Martin, A. A., Ornt, D. B., Kusek, J. W., Meyer, K. B., Levey, A. S., & for the Hemodialysis (HEMO) Study Group (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00954.x · Cited by 179
Self-citationKhan, S., & Pereira, B. J. G. (2000) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2000.00036.x · Cited by 158
Port, F. K., Wolfe, R. A., Hulbert‐Shearon, T. E., Daugirdas, J. T., Agodoa, L. Y. C., Jones, C. A., Orzol, S., & Held, P. J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.21290 · Cited by 143
Self-citation
Cited by
Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study
Cheung, A. K., Sarnak, M. J., Yan, G., Berkoben, M., Heyka, R., Kaufman, A., Lewis, J., Rocco, M., Toto, R., Windus, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00657.x · Cited by 547
Self-citationCharacteristics of sudden death in hemodialysis patients
Bleyer, A. J., Hartman, J., Brannon, P. C., Reeves-Daniel, A., Satko, S. G., & Russell, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000446 · Cited by 397
A Bench to Bedside View of Uremic Toxins
Vanholder, R., Baurmeister, U., Brunet, P., Cohen, G., Glorieux, G., & Jankowski, J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121377 · Cited by 353
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases
Argyropoulos, C. P., Chen, S. S., Ng, Y.-H., Roumelioti, M.-E., Shaffi, K., Singh, P. P., & Tzamaloukas, A. H. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00073 · Cited by 308
EBPG guideline on dialysis strategies
Tattersall, J., Martin-Malo, A., Pedrini, L., Basci, A., Canaud, B., Fouque, D., Haage, P., Konner, K., Kooman, J., Pizzarelli, F., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm022 · Cited by 262
Metadata
- Authors
- Cheung, A. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G., Clark, W., Levey, A. S., Leypoldt, J. K., Ornt, D. B., Rocco, M. V., Schulman, G., Schwab, S., Teehan, B., & Eknoyan, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2003-12
- Volume
- 14
- Issue
- 12
- Pages
- 3251-3263
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2160119333
- Cited by
- 256
- References
- 19
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study. https://app.cochat.ai/papers/10.1097/01.asn.0000096373.13406.94
- The paper
- Cheung, A. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G., Clark, W., Levey, A. S., Leypoldt, J. K., Ornt, D. B., Rocco, M. V., Schulman, G., Schwab, S., Teehan, B., & Eknoyan, G. (2003). Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000096373.13406.94
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.